| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.14 | 0.4 |